Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Moritoshi, Yamamoto"'
Autor:
Yutaka, Kimura, Hirokazu, Taniguchi, Moritoshi, Yamamoto, Junya, Fujita, Shoichiro, Fujita, Masanori, Kishibuchi, Tadashi, Onishi, Takeshi, Tono, Takushi, Monden
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 40(12)
In this retrospective study, we investigated the clinical outcomes of endoscopic gastroduodenal stenting (EGDS) for gastric outlet obstruction( GOO) caused by unresectable gastric cancer( UGC).A retrospective study was performed on 20 UGC patients wi
Autor:
Harumasa Yoshihara, Yukinori Yamada, Nao Kurashige, Eiji Masuda, Keiichi Arai, Kunio Suzuki, Nobuhiro Shirahata, Toshifumi Ito, Moritoshi Yamamoto, Osamu Nishiyama, Takenobu Kamada
Publikováno v:
Kanzo. 42:528-535
Autor:
Akira, Kaneko, Mitsuhiko, Kubo, Ryoko, Yamada, Tomoki, Tanimura, Daisuke, Yamaguchi, Moritoshi, Yamamoto, Nobuyuki, Tatsumi, Akihiro, Nakama, Eiji, Mita, Michio, Kato, Taizo, Hijioka, Masahide, Oshita, Toshifumi, Ito, Kazuho, Imanaka, Kazuhiro, Katayama, Masako, Sato, Harumasa, Yoshihara, Kazuo, Kiriyama, Yasuharu, Imai, Takeshi, Kashihara, Hiroyuki, Fukui, Kunio, Suzuki, Shio, Miyoshi, Akira, Yamada, Takayuki, Yakushijin, Kiyoshi, Mochizuki, Naoki, Hiramatsu, Tetsuo, Takehara, Norio, Hayashi
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 107(5)
The simplified international diagnostic criteria for autoimmune hepatitis (AIH), re-revised by the International AIH Group in 2008, were investigated in 114 patients with AIH from 15 centers in Japan. While applying of the criteria, we had to pay att
Autor:
Yutaka, Kimura, Hirohisa, Machida, Kazumasa, Fujitani, Moritoshi, Yamamoto, Kazunari, Tominaga, Hiroshi, Yano, Toshio, Shimokawa, Hiroya, Takiuchi, Toshimasa, Tsujinaka, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 37(1)
The standard therapy for gastric cancer with peritoneal metastasis has remained unclear.This prospective feasibility study was aimed to investigate the efficacy and safety of S-1 plus paclitaxel for advanced/recurrent gastric cancer patients with per